Protagonist Therapeutics, Inc. (PTGX)
91.59
+3.03
(+3.42%)
USD |
NASDAQ |
Dec 10, 15:39
Protagonist Therapeutics Profit Margin (Quarterly): -834.9% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.47% |
| ADMA Biologics, Inc. | 27.14% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Vanda Pharmaceuticals, Inc. | -40.15% |
| Bristol Myers Squibb Co. | 17.96% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.15% |
| Return on Assets | 6.54% |
| Return on Invested Capital | 7.03% |
| Gross Profit Margin (Quarterly) | 92.34% |
| Operating Margin (Quarterly) | -985.2% |
| Return on Net Operating Assets | 77.21% |